U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07785258) titled 'TTNS in SCI Patients With Neurogenic Detrusor Overactivity' on Feb. 19.
Brief Summary: This is a prospective, single-arm, pilot study to assess effectiveness and tolerability of transcutaneous tibial nerve stimulation (TTNS) in managing neurogenic detrusor overactivity in spinal cord injury patients. 12 - 16 spinal cord injury patients with neurogenic detrusor overactivity will be recruited. The intervention includes administration of TTNS at the highest tolerated level for 20 minutes daily for 4 weeks, using a neuromodulation device -- Tensi+.
Outcome measures including Urodynamic Study (UDS) will be retrieved or collected at base...